Skip to main content
. 2019 Sep 15;200(6):704–711. doi: 10.1164/rccm.201809-1755OC

Figure 5.

Figure 5.

Mast cell activation increases on high-dose aspirin and correlates with peripheral blood eosinophilia observed in aspirin-exacerbated respiratory disease (AERD). (A) Plasma total tryptase at baseline and on 8 weeks of high-dose aspirin in subjects with AERD and aspirin-tolerant asthma. Horizontal bars reflect group mean. **P < 0.01. (B) Plasma tryptase correlation (Pearson) with peripheral blood eosinophil counts on high-dose aspirin in subjects with AERD. ASA = aspirin; ATA = aspirin-tolerant asthma.